Implications for employers: - This demonstrates that two of the GLP-1 drugs (tirzepatide and semaglutide, both injectable) are associated with much more weight loss than even especially effective diets
In this article, well break down the latest evidence, side effect profiles, and long-term considerations to help you make an informed decision on GLP-1 therapy
Psychoneuroendocrinology repositioning of diabetes treatments for depressive symptoms : a systematic review and meta-analysis of clinical trials
This is technically the desired effect, but its intensity can surprise first-time users
The result is a very sudden drop in your blood sugar levels
Noom partnered with Waltz Health to provide direct, cost-effective access to GLP-1 medications, bypassing traditional intermediaries and reducing overall treatment costs for employers